The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAscential Regulatory News (ASCL)

Share Price Information for Ascential (ASCL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 314.00
Bid: 314.00
Ask: 315.80
Change: 0.00 (0.00%)
Spread: 1.80 (0.573%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 314.00
ASCL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Perpetua Labs Inc

15 Apr 2021 07:00

RNS Number : 5181V
Ascential PLC
15 April 2021
 

THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED TO CONSTITUTE INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATIONS.

 

 

15 April 2021

 

Ascential plc

 

Acquisition of Perpetua

 

 

Ascential plc (LSE: ASCL.L), the specialist information, analytics and eCommerce optimisation company, today announces the acquisition of Perpetua Labs Inc, an eCommerce media optimisation business that primarily targets Third party (3P1) sellers.

 

Perpetua provides a self-service SaaS platform that helps independent sellers, as well as agencies and some larger brands, optimise the purchase of search and display advertising on Amazon and other major marketplaces. This marks new territory for Ascential's Digital Commerce segment, which the business will join, and which to date has exclusively served first party (1P) vendors. Perpetua has 66 staff, based primarily in Toronto, which include the founder and CEO Rosco Hill who is the largest shareholder.

 

The acquisition is for an initial cash consideration of US$52m, plus deferred consideration payable over four years, resulting in an estimated total consideration (including the initial consideration) of between US$103m and US$162m. Total consideration payable for Perpetua, in the event that very stretching targets are reached, is capped at US$250m.

 

In the year ended December 2020 Perpetua recorded revenue of US$3.8m (growth of over 3x vs 2019) and an EBITDA loss of US$0.2m. At December 2020 it had annualised MRR2 of US$7.4m, with gross assets of US$10.9m.

 

Duncan Painter, CEO of Ascential, commented:

"Perpetua's expertise serving third party vendors, through data-driven solutions, opens the door for Ascential to this large and fast-growing market segment. Combined with the global reach of our existing Digital Commerce businesses, that provide a full service offering to larger, First party, brands, we have the exciting opportunity, with Perpetua, to expand our offerings across further platforms and geographies."

 

 

1 3P: Third (vs First) party, selling directly to consumers, via digital platforms

2 Monthly Recurring Revenue

 

 

 

Contacts

 

Ascential plc

Duncan Painter

Chief Executive Officer

+44 (0)20 7516 5000

Mandy Gradden

Chief Financial Officer

Rory Elliott

Investor Relations Director

Media enquiries

Edward Bridges, Matt Dixon, Jamie Ricketts

FTI Consulting LLP

+44 (0)20 3727 1017

 

 

About Ascential

Ascential delivers specialist information, analytics and eCommerce optimisation platforms to the world's leading consumer brands and their ecosystems.

 

Our world-class businesses improve performance and solve problems for our customers by delivering immediately actionable information combined with visionary longer-term thinking across Digital Commerce, Product Design and Marketing. We also serve customers across Retail & Financial Services.

 

· Digital Commerce - measurement, optimisation and execution for digital commerce growth.

· Product Design - consumer product trend forecasting, data and insight to create world-class products and experiences.

· Marketing - services and tools to measure and optimise marketing creativity, media and platform effectiveness and efficiency.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLZLLFFZLLBBZ
Date   Source Headline
5th Jan 20217:00 amRNSAppointment of Non-Executive Directors
16th Dec 20207:00 amRNSAcquisition of Digital Commerce businesses
15th Dec 20204:34 pmRNSHolding(s) in Company
15th Dec 20207:00 amRNSSale of Glenigan for £72.9m
10th Dec 20207:00 amRNSTrading update and segmental restatement
26th Nov 20202:07 pmRNSHolding(s) in Company
16th Nov 202011:42 amRNSHolding(s) in Company
5th Nov 202012:01 pmRNSHolding(s) in Company
22nd Oct 20204:25 pmRNSHolding(s) in Company
7th Oct 20201:02 pmRNSHolding(s) in Company
2nd Oct 20201:37 pmRNSDirector/PDMR Shareholding
1st Oct 20204:53 pmRNSTotal Voting Rights
29th Sep 20207:00 amRNSCOO Appointment
18th Aug 20201:21 pmRNSHolding(s) in Company
12th Aug 20204:33 pmRNSDirector/PDMR Shareholding
4th Aug 20207:00 amRNSMoney20/20 US and Europe 2020 cancellations
31st Jul 202012:10 pmRNSExternal Directorship
27th Jul 20207:05 amRNSAppointment of Non-Executive Director
27th Jul 20207:00 amRNSHalf-year Report
21st Jul 20204:14 pmRNSNotice of Interim Results date
6th Jul 202012:00 pmRNSHolding(s) in Company
6th Jul 202011:59 amRNSHolding(s) in Company
11th Jun 20204:00 pmRNSDirector Declaration
2nd Jun 202011:14 amRNSTotal Voting Rights
18th May 202010:06 amRNSDirector/PDMR Shareholding
7th May 20202:44 pmRNSDirector/PDMR Shareholding
6th May 20201:35 pmRNSResult of AGM
1st May 202011:33 amRNSTotal Voting Rights
29th Apr 20207:00 amRNSCovenant amendments and Q1 trading update
21st Apr 20205:02 pmRNSHolding(s) in Company
20th Apr 20204:38 pmRNSUpdate on 2020 AGM
16th Apr 20205:02 pmRNSHolding(s) in Company
3rd Apr 20202:30 pmRNSHolding(s) in Company
3rd Apr 20207:00 amRNSCannes Lions Cancellation & Other Actions
2nd Apr 20201:00 pmRNSEdge by Ascential launches Market Share 2.0
1st Apr 20205:23 pmRNSTotal Voting Rights
24th Mar 20202:00 pmRNSMoney20/20 Europe deferral to September 2020
18th Mar 20201:00 pmRNSCannes Lions deferral to contingency dates
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20209:37 amRNSHolding(s) in Company
12th Mar 20205:51 pmRNSTransaction in Own Shares
11th Mar 20205:26 pmRNSTransaction in Own Shares
11th Mar 202012:00 pmRNSContingency Dates - Cannes Lions & Money20/20 Eu
10th Mar 20205:39 pmRNSTransaction in Own Shares
9th Mar 20205:21 pmRNSTransaction in Own Shares
6th Mar 20204:57 pmRNSTransaction in Own Shares
5th Mar 20205:04 pmRNSTransaction in Own Shares
4th Mar 20205:32 pmRNSTransaction in Own Shares
3rd Mar 20204:42 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.